Accurel Pharmaceuticals Private Limited
About Accurel Pharmaceuticals Private Limited
Data last updated:
Accurel Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the social services and community development segment of the non-profit sector. It was incorporated on 08 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85320MH2019PTC327721. Its GSTIN is 27AASCA4819Q1ZS (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Bindu Singh and Shhyam Narayan Siingh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No 301 Bldg 30 Evershine Millennium Paradise Thakur Village Kandivali (E), Mumbai, Maharashtra, India – 400101.
As per the financials filed for FY 2025, the company reported a revenue of ₹47.27 Lakh, a decline of 47% compared to the previous year. For the same year it recorded a net loss of ₹77.25 Lakh (net margin -163.4%) and EBITDA of -₹76.33 Lakh (EBITDA margin -161.5%).
The company has about 13 employees on its provident fund (EPFO) records.
Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFlat No 301 Bldg 30 Evershine Millennium Paradise Thakur Village Kandivali (E), Mumbai, Maharashtra, India – 400101
- IndustryNon-Profit Organizations, Social Work, Social Work Activities Without Accommodation
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Accurel Pharmaceuticals Private Limited
The main business activity of Accurel Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Accurel Pharmaceuticals Private Limited FY 2025 filings available
Accurel Pharmaceuticals Private Limited reported revenue of ₹47.27 Lakh (down 47% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Accurel Pharmaceuticals Private Limited
Revenue fell 47% in the latest year. EBITDA fell 507% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Accurel Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹76.33 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹77.25 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Accurel Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -161.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -163.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Accurel Pharmaceuticals are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Accurel Pharmaceuticals Private Limited
Accurel Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Triumph Pharmaceuticals Private Limited | ₹47.46 Lakh (FY 2025) | •••• | •••• | 5.0% | •••• | Mysore, Karnataka, India |
| Gehirn Pharmaceuticals Private Limited | ₹47.38 Lakh (FY 2024) | •••• | •••• | •••• | Jabalpur, Madhya Pradesh, India | |
| Drtherapeutics International Pharmaceuticals Private Limited | ₹47.37 Lakh (FY 2025) | •••• | •••• | -13.0% | •••• | Pune, Maharashtra, India |
| Invocation Pharmaceuticals Private Limited | ₹47.32 Lakh (FY 2025) | •••• | •••• | -4.0% | •••• | Jaipur, Rajasthan, India |
| Macmantus Pharmaceuticals Private Limited | ₹47.3 Lakh (FY 2023) | •••• | •••• | •••• | Gwalior, Madhya Pradesh, India | |
| Accurel Pharmaceuticals Private Limited this company | ₹47.27 Lakh (FY 2025) | •••• | •••• | -47.0% | •••• | Mumbai, Maharashtra, India |
| Jivan Sambridhi Pharmaceuticals Private Limited | ₹47.25 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Kolkata, West Bengal, India |
| KHK Pharmaceuticals Private Limited | ₹47.22 Lakh (FY 2023) | •••• | •••• | 183.0% | •••• | New Delhi, Delhi, India |
| Inverse Pharmaceuticals Private Limited | ₹47.09 Lakh (FY 2023) | •••• | •••• | 42.0% | •••• | Kanpur, Uttar Pradesh, India |
| Sulzderma Pharmaceuticals Private Limited | ₹47.07 Lakh (FY 2024) | •••• | •••• | -8.0% | •••• | Nagpur, Maharashtra, India |
| Fidrok Pharmaceuticals Private Limited | ₹47.05 Lakh (FY 2025) | •••• | •••• | 4605.0% | •••• | Gmc, Assam, India |
Peers are the five companies nearest above and the five nearest below Accurel Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Accurel Pharmaceuticals Private Limited
Accurel Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bindu Singh | Director | 08 Jul 2019 | 7 Years 3 Months | Current |
| Shhyam Narayan Siingh | Director | 28 Jul 2023 | 3 Years 2 Months | Current |
| Abhishree Shhyam Narayan Siingh | Director | 22 Jan 2026 | 0 Years 8 Months | Current |
Ownership and Shareholding of Accurel Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Accurel Pharmaceuticals Private Limited
Accurel Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Accurel Pharmaceuticals Private Limited
Accurel Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Accurel Pharmaceuticals. All case is pending. Status as checked on 30 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed by the company against an individual | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Accurel Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Accurel Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Accurel Pharmaceuticals Private Limited
Accurel Pharmaceuticals Private Limited has 5 board changes on record since 2019: 3 appointments and 2 cessations. The latest: Abhishree Shhyam Narayan Siingh was appointed as Director on 22 Jan 2026.
Credit Ratings, Litigation & Regulatory Alerts for Accurel Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Accurel Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Accurel Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Accurel Pharmaceuticals Private Limited
Accurel Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AASCA4819Q1ZS | Maharashtra | Active | 25 Dec 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Accurel Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Accurel Pharmaceuticals Private Limited
Accurel Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in social work, within the non-profit organizations industry. It was incorporated on 08 July 2019 (7+ years old) and is registered under CIN U85320MH2019PTC327721.
Accurel Pharmaceuticals reported revenue of ₹47.27 Lakh for FY 2025 (down 47% YoY).
Accurel Pharmaceuticals has 3 current directors:
- Bindu Singh - Director
- Shhyam Narayan Siingh - Director
- Abhishree Shhyam Narayan Siingh - Director
Accurel Pharmaceuticals reported a net loss of ₹77.25 Lakh (net margin -163.4%) and EBITDA of -₹76.33 Lakh (EBITDA margin -161.5%) for FY 2025, as per its filed financial statements.
The GSTIN of Accurel Pharmaceuticals is 27AASCA4819Q1ZS, registered in Maharashtra.
The CIN (Corporate Identification Number) of Accurel Pharmaceuticals is U85320MH2019PTC327721. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Accurel Pharmaceuticals has 1 court case on record: 1 filed by the company. 1 is pending.
Accurel Pharmaceuticals was incorporated on 08 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Accurel Pharmaceuticals by revenue are Triumph Pharmaceuticals Private Limited, Gehirn Pharmaceuticals Private Limited, Drtherapeutics International Pharmaceuticals Private Limited, Invocation Pharmaceuticals Private Limited, Macmantus Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Abhishree Shhyam Narayan Siingh was appointed as Director on 22 Jan 2026. Abhishree Shhyam Narayan Siingh ceased to be Director on 28 Jul 2023. Shhyam Narayan Siingh was appointed as Director on 28 Jul 2023. Accurel Pharmaceuticals has 5 board changes on record in total.
The registered office of Accurel Pharmaceuticals is at Flat No 301 Bldg 30 Evershine Millennium Paradise Thakur Village Kandivali E, Mumbai, Maharashtra, India – 400101.